Enzymes for Industrial Applications

Report Highlights

• Total U.S. consumption of enzymes is estimated at $514 million in 2000.
• Growing at an average annual rate (AAGR) of 4.1%, usage will reach $629.3 million by 2005.
• Pulp and paper applications will show the most growth, at an AAGR of 6.5% through the period.
• Detergent/cleaners are second, with 5% annually on average. Food and animal feed applications dominate the current market, accounting for just under half the total value.

INTRODUCTION

This report presents the findings of an analysis of the U.S. market for industrial enzymes.

STUDY GOALS AND OBJECTIVES

This report is intended to bring to the reader a detailed analysis of the industrial applications of enzymes, with emphasis on future trends, changing technology, and opportunities.

The major objectives of this study are as follows:

• To make available the most current and reliable information on consumption of industrial enzymes.
• To forecast the market for these applications, broken down insofar as possible by end use and by individual enzyme or group of enzymes.
• To identify the most rapidly changing applications and the reason for their growth or decline.
• To describe the major trends in the end uses.
• To provide profiles of the most important companies supplying industrial enzymes.

REASONS FOR DOING THE STUDY

Most of the writing that has been done on enzymes has been academic, about enzymes that have little or no sales. This study seeks to put perspective on the field of industrial enzymes by examining the applications actually being practiced commercially.

SCOPE OF THE STUDY

This study covers industrial applications of enzymes: food and animal feed, detergents, textiles, leather and fur, paper and pulp, and chemicals manufacturing (commodity and fine). All industrial applications within these major categories are included.

Excluded from this study are enzymes for analytical (diagnostic) applications, enzymes for biotechnology (biology and genetic engineering) applications, and enzymes for medical (drug) applications.

This study generally excludes broad fermentation processes, i. e. it excludes the enzymatic aspects of microorganisms, used as living whole cells in culture, for the commercial production of end products such as antibiotics, bread and the like.

METHODOLOGY AND SOURCES OF INFORMATION

This study is basically an update of BCC study C-147NA, on the same subject, except that it is based on U.S. consumption of enzymes, not the world, although world usage is estimated in the section on International Aspects. The information in the above report has been updated by use of more current published information, supplemented by interviews with key industry personnel.

UNITS

All forecasts are given in constant 2000 dollars. Growth rates are compounded annually.